Intradermal Vaccination of Adults with Three Low Doses (2 μg) of Recombinant Hepatitis B Vaccine. II. Persistence of Immunity and Induction of Immunologic Memory
نویسندگان
چکیده
Of the 110 dentists who had presented seroconversion 50 days after the intradermal application of three 2 μg doses of the Belgian recombinant vaccine against hepatitis B (HB), administered eight years before at an interval of one month between the 1st and 2nd doses and of five months between the 2nd and 3rd doses, 51 were included for the assessment of the persistence of immunity. None of the dentists had hepatitis or had received HB vaccine during this period. All subjects were submitted to serological tests for the detection of the following markers of hepatitis B virus (HBV) infection: HBsAg, anti-HBc, HBeAg, anti-HBe, and anti-HBs, with no HBsAg, anti-HBc, HBeAg or antiHBe being detected. A microparticle enzyme immunoassay (MEIA) revealed the presence of anti-HBs at protective titers (≥ 10 mIU/ml) in 42 dentists (82.4%), with the anti-HBs titer being higher than 100 mIU/ml in 36 of them (70.6%) (good responders), between 10 and 100 mIU/ml in 6 (11.8%) (poor responders), and lower than 10 mIU/ml in 9 (17.6%) (non-responders). According to clinical data and serological tests, none of the dentists had presented disease or latent HBV infection during the eight years following the first vaccination. A 2 μg booster dose was administered intradermally to eight dentists with anti-HBs titers lower than 10 mIU/ml (non-responders) and to six dentists with titers ranging from 10 to 100 mIU/ml (poor responders); the determination of anti-HBs one month later demonstrated the occurrence of seroconversion in the eight non-responders and an increase in anti-HBs titer in the six poor responders. In summary, the present results demonstrated the prolonged persistence of protection against HBV infection and the development of immunologic memory provided by vaccination against HB – with intradermal application of three 2 μg doses of the Belgian recombinant vaccine at 0, 1, and 6 months – carried out eight years before in 51 dentists.
منابع مشابه
Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. II. Persistence of immunity and induction of immunologic memory.
Of the 110 dentists who had presented seroconversion 50 days after the intradermal application of three 2 micrograms doses of the Belgian recombinant vaccine against hepatitis B (HB), administered eight years before at an interval of one month between the 1st and 2nd doses and of five months between the 2nd and 3rd doses, 51 were included for the assessment of the persistence of immunity. None ...
متن کاملAnti-HBs Response and its Protective Effect in Children and Adults Receiving Hepatitis B Recombinant Vaccine in Tehran
Background: Following WHO recommendation, HBV vaccination has been integrated into EPI program in Iran since 1996. Objective: To evaluate the immunogenicity and protective effect of HB vaccine (recombinant Heberbiovac ,Cuba ) in vaccinated children and adults . Methods: A total of 542 cases (340 children and 202 adults) were vaccinated using a three-doses schedule of zero, one and six month. ...
متن کاملPersistence of immunity to hepatitis B vaccine as infants, 17 years earlier
Background: In Iran scince 1992, hepatitis B vaccination was a part of the national vaccination program. Hepatitis B vaccination is effective in the epidemiology of hepatitis B. The aim ofthis study was to evaluate the long – term persistence of immunity. Methods: This cross-sectional analytical study was conducted on children and adolescents aged between 6-18 years in Birjand, who recei...
متن کاملبررسی دوام آنتی بادی anti-HBs و خاطره ایمنی واکسن هپاتیت B ، 18 سال پس از واکسیناسیون دوره نوزادی در دانشجویان دانشگاه تهران
Background The duration of infantile hepatitis B vaccination-induced immunity is still unknown. We assessed antibody persistence and immunological memory to hepatitis B 18 years after vaccination during infancy in Iranian young adults at risk of hepatitis B virus infection due to behavioral or occupational exposures. Methods This study was conducted on 395 freshman students of with a history of...
متن کاملایمنیزایی واکسن هپاتیت B در دانشجویان علوم پزشکی مازندران
Background and purpose: Vaccination is the most effeetive method of prophylaxy in high risk group of hepatitis B. Some individuals faile to respond to triple doses of vaccine which is potentially dangerous. Therefore, immunogenecity of triple doses recombinant hepatitis B vaccine was evaluated in a high risk group (medical sciences students). Materials and Methods: 193 healthy medical scie...
متن کامل